Neuraxpharm expands into the Netherlands The CNS specialist continues its strong expansion course in Europe and increases its presence from two to 20 countries in just six years Naarden and Düsseldorf – December 7, 2022 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharma.
/PRNewswire/ Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS).